Christopher L. Bowlus

A Placebo-Controlled Trial of Obeticholic Acid in Primary Biliary Cholangitis

Frederik Nevens, Pietro Andreoné, G. Mazzella et al. · New England Journal of Medicine · 2016 · 1.1K citations · Full text

Medicine, Pharmacology, Pharmacotherapy +16

Primary Biliary Cholangitis: 2018 Practice Guidance from the American Association for the Study of Liver Diseases

Keith D. Lindor, Christopher L. Bowlus, James L. Boyer et al. · Hepatology · 2018 · 883 citations · Full text

Medicine, Internal Medicine, Radiology +16

Exenatide effects on diabetes, obesity, cardiovascular risk factors and hepatic biomarkers in patients with type 2 diabetes treated for at least 3 years

David C. Klonoff, John B. Buse, Loretta L. Nielsen et al. · Current Medical Research and Opinion · 2007 · 700 citations

Medicine, Endocrinology, Pharmacology +13

Patient Age, Sex, and Inflammatory Bowel Disease Phenotype Associate With Course of Primary Sclerosing Cholangitis

Tobias J. Weismüller, Palak Trivedi, Annika Bergquist et al. · Gastroenterology · 2017 · 523 citations · Full text

Medicine, Internal Medicine, Pathology +13

Genome-wide association study of primary sclerosing cholangitis identifies new risk loci and quantifies the genetic relationship with inflammatory bowel disease

Sun‐Gou Ji, Brian D. Juran, Sören Mucha et al. · Nature Genetics · 2016 · 382 citations · Full text

Life Sciences, Genetics, Molecular Genetics +17